Our study highlights a keratinocyte-intrinsic AhR-Ovol1-Id1 regulatory axis that functions at the environment-barrier-immune interfaces to protect skin homeostasis against skin inflammation and implicates new therapeutic targets for both AD and psoriasis. This evidence concerns the gene ID1 and psoriasis.